|
|
|
Volumn 9, Issue 4, 2006, Pages 253-255
|
|
Translational medicine 2006. 14-15 February 2006, London, UK
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFECTIVE AGENT;
CARDIOVASCULAR AGENT;
NEW DRUG;
NOOTROPIC AGENT;
APPLIED RESEARCH;
CLINICAL TRIAL;
CONFERENCE PAPER;
DECISION MAKING;
DEMENTIA;
DRUG CLEARANCE;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG INDUSTRY;
DRUG LEGISLATION;
DRUG RESEARCH;
DRUG SAFETY;
FATIGUE;
FINANCIAL MANAGEMENT;
FUNDING;
HEADACHE;
HUMAN;
NAUSEA;
NONHUMAN;
PREDICTION;
PUBLIC HEALTH;
RISK ASSESSMENT;
RISK BENEFIT ANALYSIS;
VALIDATION PROCESS;
ANIMALS;
ANTI-ANXIETY AGENTS;
ANXIETY;
BIOMEDICAL RESEARCH;
CENTRAL NERVOUS SYSTEM DISEASES;
CLINICAL TRIALS;
DRUG EVALUATION, PRECLINICAL;
DRUG INDUSTRY;
HUMANS;
|
|
EID: 33646040102
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (1)
|
|
References (0)
|
